Radar · Life Sciences Platforms and Tools in Ile de France
Best Life Sciences Platforms and Tools Companies in Ile de France, France
The 74 best Life Sciences Platforms and Tools companies in Ile de France, France in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: DNA Script.
By Rohit KhannaTrends & Stories
74companies tracked
$843.6Mdisclosed funding
0unicorns
41have raised
FLIAR INTELLIGENCE · LIFE SCIENCES PLATFORMS AND TOOLS × ILE DE FRANCE
Our analysis of 50 Life Sciences Platforms and Tools companies
$4.8b in tracked funding; 68% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
50companies analysed
68%cloud-native stacks
2025funding peak (by rounds)
2unicorns
2013median founding year
225kcombined LinkedIn audience
29%of audience held by top 3
5companies hiring publicly (12 mo)
Ranked: Best Life Sciences Platforms and Tools companies in Ile de France
| # | Company | Disclosed funding | Last round | Employees | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|
| 1 | DNA Script Developer of benchtop DNA printer for nucleic acid synthesis | $315M | 33 mo ago | 202 | Xavier Godron Co-founder & CTO | WordPress Block EditorWordPressBugHerd+30 | 334 patents Enzymatic, template‑free nucleic acid synthesis and purification for custom DNA manufacturing | — |
| 2 | HiFiBiO Provider of a technology platform for the discovery of antibody-based drugs | $180M | 60 mo ago | 75 | Liang Schweizer Founder | — | 36 patents Ligand‑receptor pair identification and biosensor assay technologies for drug discovery | — |
| 3 | AFYREN Provider of analytical services for microbiology, chemistry and bioprocesses industries 40Funding top 25%Talent top 28%Moat top 35%Patents top 37% All 11 signals ▾Fundingtop 25% Talenttop 28% Moattop 35% Patentstop 37% Techtop 43% Innovationtop 48% Growthtop 48% Newsbottom 49% Globalbottom 40% Marketbottom 32% Fin. healthbottom 20% Funding: Raised $96.9M across 7 rounds · 7 rounds over 11 yrs (0.6/yr) Talent: 3 named leaders on record · 3 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 40/100 | $97M | 2 mo ago | 32 | Regis Nouaille Co-Founder | WordPress Site EditorWordPressMySQL+24 | 118 patents Recovery and purification of potassium salts and metabolites from anaerobic fermentation processes | — |
| 4 | Stilla Technologies Developer of digital PCR solution for research | $53M | 55 mo ago | 100 | Clement Gay Co-Founder | WordPress Block EditorWordPressMySQL+25 | — | — |
| 5 | Phagos Developer of AI-powered bioplatform for targeted bacterial treatments using phages 64Funding top 34%AI top 35%Global top 45%Talent top 45% All 5 signals ▾Fundingtop 34% AItop 35% Globaltop 45% Talenttop 45% Techbottom 45% Funding: Raised $31.6M across 2 rounds · 2 rounds over 1 yrs (2.0/yr) AI: Product described with: ai-powered, artificial intelligence rank vs industry peers · Fliar Intelligence Index 64/100 | $32M | 8 mo ago | — | Adèle James Co-Founder & CTO | Framer SitesReactMicrosoft Clarity+9 | — | 1 award |
| 6 | Qubit Pharmaceuticals Developer of drugs for the treatment of cancer and inflammatory diseases | $25M | 45 mo ago | 50 | Jay Ponder Co-Founder | WebflowApple iCloud MailGoogle Workspace+14 | 15 patents Quantum algorithms for molecular simulation and optimized quantum circuit design for chemistry | 1 partnership |
| 7 | Metafora Biosystems Provider of diagnostic tests and reagents for research | $23M | 41 mo ago | 32 | Luc Dauriol Co-Founder & Chairman | — | 37 patents Diagnostic biomarkers and computational tools for single‑cell analysis in hematology | — |
| 8 | Astraveus Provider of a device for autologous cell and gene therapies | $18M | 18 mo ago | 29 | Jeremie Laurent Founder & CEO | WordPressMySQLPHP+25 | 51 patents Parallel microfluidic bioprocessing platforms for high‑throughput cell and particle handling | — |
| 9 | Core Biogenesis Provider of UBaaS platform for recombinant protein bioproduction | $14M | 50 mo ago | 39 | Chouaib Meziadi CSO | — | 9 patents Patents concentrated in chemistry & materials | — |
| 10 | Meiogenix Developer of novel breeding technologies for crop plants | $13M | 54 mo ago | 7 | Luc Mathis CEO | WebflowGSAPMicrosoft Advertising+10 | 39 patents CRISPR‑based tools for engineered meiotic recombination and genome editing | — |
| 11 | Okomera Developer of a device for in vitro cancer testing using a microfluidic chip | $11M | 30 mo ago | 15 | Aimee Wessel Co-Founder & CEO | Webflow EcommerceWebflowPlausible+7 | 2 patents Microfluidic droplet generation and collection devices for precise fluid handling | — |
| 12 | Aenitis Developer of acoustic based tools for cell sorting | $10M | 60 mo ago | 13 | Emmanuel VINCENT Co-Founder & CEO | — | — | — |
| 13 | Spore Biotechnologies Developer of microbial detection technology for life science industries 53AI top 15%Growth top 35%Talent top 38%Funding top 42% All 10 signals ▾AItop 15% Growthtop 35% Talenttop 38% Fundingtop 42% Moattop 42% Techtop 43% Patentstop 46% Innovationbottom 47% Globalbottom 39% Marketbottom 23% AI: Holds AI/ML patents (G06N-family CPC) Growth: Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 53/100 | $9M | 5 mo ago | 5 | Amine Raji Co-Founder & CEO | RubyAnimate.cssVarnish+12 | 7 patents Rapid optical detection of bacteria in samples using spectroscopic sensor technology | 1 job opening · 1 award |
| 14 | Scipio Bioscience Develops sample preparation solutions | $8M | 36 mo ago | 44 | Pierre Walrafen Co-Founder & CEO | — | 19 patents Hydrogel-based spatial omics platforms for single-cell capture and barcoding | — |
| 15 | One Biosciences Developer of single-cell therapeutics solutions to treat multiple health disorders | $5M | 11 mo ago | — | Celine Vallot Co-Founder | WordPressMySQLPHP+7 | — | 1 partnership · 2 awards |
| 16 | Novacyt A molecular diagnostics company specializing in genomic medicine solutions | $4M | 96 mo ago | 222 | — | WordPressApple iCloud MailMySQL+25 | 133 patents Automated sample prep and digital cytology/histology analysis for cellular diagnostics | — |
| 17 | Elveflow Developer of flow control systems | $4M | 55 mo ago | 45 | Eric Farin CEO | WordPressMySQLRedis+31 | — | — |
| 18 | Inorevia Developer of microfluidics platform | $3M | 48 mo ago | 16 | Laurent Malaquin Co-Founder | — | 8 patents Microfluidic droplet manipulation, sorting, and individual droplet extraction technologies. | — |
| 19 | ScreenCell Developer of circulating tumor cells | $3M | 113 mo ago | 11 | — | — | 32 patents Microfluidic biomarker assays for circulating tumor cell detection and sickle‑cell diagnostics | — |
| 20 | Eden Tech Provider of microfabrication solutions for bioinspired microfluidics technologies | $2M | 54 mo ago | — | Emmanuel Roy Co-Founder & CEO | WordPressMySQLPHP+31 | — | 1 launch |
| 21 | Abbelight Provider of solutions for microscopes, reagents, and software for image analysis 57AI top 15%Product top 30%Moat top 32%Innovation top 40% All 9 signals ▾AItop 15% Producttop 30% Moattop 32% Innovationtop 40% Patentstop 40% Fundingtop 42% Techbottom 48% Marketbottom 42% Globalbottom 36% AI: Holds AI/ML patents (G06N-family CPC) Product: 4 distinct product lines · Company stage: Series B rank vs industry peers · Fliar Intelligence Index 57/100 | $2M | 5 mo ago | 42 | — | WordPressMySQLPHP+19 | 24 patents Super-resolution single-molecule fluorescence microscopy hardware and image‑saving methods | 2 awards |
| 22 | Omini Developer of point-of-care lab-on-chip devices for immediate blood tests | $2M | 64 mo ago | 29 | — | — | — | 1 internship · 1 award |
| 23 | CryoCap cells Manufactures sample preparation systems for electron microscope | $2M | 112 mo ago | 8 | — | — | — | — |
| 24 | Minos Biosciences Developer of a sequencing-based multi-omic analysis device | $2M | 62 mo ago | 11 | Hubert Geisler Co-founder & Head of Microfluidics | — | — | — |
| 25 | GreenTropism Provider of software components for mainstream and industrial spectroscopy | $1M | 106 mo ago | 13 | Anthony Boulanger Founder & CEO | — | 31 patents Rapid pathogen detection in biological fluids using surface-enhanced Raman spectroscopy | — |
| 26 | EVerZom Developer of a technology platform for the production of extracellular vesicles | $1M | 12 mo ago | 17 | Max Piffoux Co-Founder & CTO | WordPress Block EditorWordPressMySQL+18 | — | — |
| 27 | Alveole Developer of device for in vitro cell microenvironment model | $1M | 92 mo ago | 20 | Romuald Vally CEO | — | 46 patents Biofabrication of patterned hydrogels and proteins with large-field 3D spectral microscopy | — |
| 28 | Millidrop Provider of cell culture machines based on milli fluidics technology for bacteriological research | $1M | 93 mo ago | 5 | — | — | — | — |
| 29 | Phenocell Provider of cell-based assays for drug discovery | $942K | 125 mo ago | — | — | — | 2 patents Deriving human sebocyte precursor cells from iPSCs for dermatological cell therapy | — |
| 30 | Xentech Patient-Derived tumor Xenograft patform offering preclinical cancer models and services for translational… | $765K | 125 mo ago | 31 | — | — | 10 patents Predictive cancer biomarker diagnostics for chemotherapy and PARP inhibitor response | — |
| 31 | Glowee Provider of bioluminescent lighting solutions | $678K | 36 mo ago | 25 | Sandra Rey Founder & CEO | WordPressMySQLPHP+17 | 10 patents Engineered bioluminescent proteins and bacterial systems for sustainable lighting of façades and decorative panels. | — |
| 32 | Elvesys Microfluidics Manufacturer of microfluidic instruments for flow control, measurement, and detection | $638K | 113 mo ago | 15 | — | — | — | 1 job opening · 1 partnership |
| 33 | Primadiag Robotics platforms for rapid automation of biology protocols | $518K | 204 mo ago | 21 | Gregory Meunier CEO | — | 5 patents Magnetic bead handling modules for robotic automation in bio‑lab assays | — |
| 34 | Biospace Lab Develops and markets ex-vivo and in-vivo molecular imaging systems | $283K | 93 mo ago | 11 | Lise Laumonier CEO and Board Member | — | 26 patents Optical luminescence imaging systems for biomedical diagnostics and PET imaging | — |
| 35 | Kolibri Developer of acoustic wave-based bioreactors to handle mammalian cells | $250K | 33 mo ago | 11 | Gabriel dumy Co-Founder | — | 3 patents Acoustic microfluidic cell culture platforms for compartmentalized tissue engineering | — |
| 36 | Anova Plus Developd diagnostic and decision support tools for agro-industry | $223K | 77 mo ago | — | Marc Masson Founder | — | 11 patents Field diagnostic assays for multi‑resistant fungal pathogens in cereals and human/animal health | — |
| 37 | Microfactory Microfluidic devices for research | $121K | 100 mo ago | — | Fabrice Monti Co-Founder | — | 30 patents Hydrogel-based 3D cell/organelles analysis and skin-mimetic testing platforms | — |
| 38 | Photeomix Detection of differentially active components of the proteome | $53K | 126 mo ago | — | Iain Pemberton Founder & Executive Director | — | — | — |
| 39 | Cyprio Developer of liver mimicking speriodal cell culture for in-vivo studies | $50K | 80 mo ago | — | Noushin Dianat Co-Founder & CEO | — | — | — |
| 40 | Sebia Developer of electrophoresis-based in vitro diagnostics products | — | 41 mo ago | 87 | — | WordPressSentryApple iCloud Mail+24 | 106 patents Patents concentrated in computing, sensing & instrumentation | — |
Top 12 Life Sciences Platforms and Tools companies in Ile de France
#1
Public · Paris, Ile de France · founded 2012 · 32 employees$96.9Mraised▾
Public · Paris, Ile de France · founded 2012 · 32 employees
Provider of analytical services for microbiology, chemistry, and bioprocesses industries. It has developed its product known as Afynerie, technology, which directly valorizes non-food biomass (wastes) into biomolecules of high energetical and chemical interest. The company offers services including the measurement of methane volume (or more generally biogas) produced by degradation of organic substrates by anaerobic microorganisms, & organic substrates physicochemical characterization.
Fliar Intelligence Index™ 40how this company ranks against its industry peers
Funding
top 25%Talent
top 28%Moat
top 35%Patents
top 37%Tech
top 43%Innovation
top 48%Funding: Raised $96.9M across 7 rounds · 7 rounds over 11 yrs (0.6/yr) · Last round Grant (prize money) (Apr 2026)
Talent: 3 named leaders on record · 3 C-suite/founder profiles curated
Moat: Editorial + unicorn rating 5/10 · IP moat: 118 patents · 9 curated direct competitors tracked
Audience (LinkedIn): 20k LinkedIn followers — 8.8% of this cohort's audience · 57 engagements/post (1.8× cohort median)
Funding rounds
- Apr 2026Grant (prize money)$3.5M
- Feb 2026Post IPO$8.2M
- Nov 2025Post IPO$26.6M
- Jul 2025Grant (prize money)$4.7M
Founders & team
Investors
JEREMIE AUVERGNE, Valquest Capital Management, Sofinnova Partners, Bpifrance, Kemin, Odyssee Venture
Tech stack
Apache Http ServerComplianzContact Form 7Core-JsDropzoneFormidable Form
#2
Series A · Suresnes, Ile de France · founded 2021$31.6Mraised▾
Series A · Suresnes, Ile de France · founded 2021
Developer of AI-powered bioplatform for targeted bacterial treatments using phages. The platform combines microbiology and artificial intelligence to design treatments using phages. Treatments are continuously updated to ensure subjects stay healthy. The solution is being deployed across chicken, cattle, swine, and shrimp sectors.
Fliar Intelligence Index™ 64how this company ranks against its industry peers
Funding
top 34%AI
top 35%Global
top 45%Talent
top 45%Tech
bottom 45%Funding: Raised $31.6M across 2 rounds · 2 rounds over 1 yrs (2.0/yr) · Last round Series A (Oct 2025)
AI: Product described with: ai-powered, artificial intelligence
Global: Investors from 3 countries beyond France
Audience (LinkedIn): 12k LinkedIn followers — 5.3% of this cohort's audience
Activity (LinkedIn): 1 awards announced in 12 mo
Funding rounds
- Oct 2025Series A$29.2M
- Sep 2025Seed$2.4M
Founders & team
Investors
Capagro, Hoxton Ventures, Demeter, Caphorn, Acurio Ventures, Entrepreneur First
Tech stack
Core-JsFramer SitesGoogle AnalyticsGoogle Font ApiGoogle WorkspaceHsts
#3
Series A · Paris, Ile de France · founded 2022 · 5 employees$8.6Mraised▾
Series A · Paris, Ile de France · founded 2022 · 5 employees
Developer of microbial detection technology for life science industries. The company is developing innovative technologies to detect bacterial and microbial risk for various industries food&beverage, cosmetics, and pharmaceutics manufacturers.
Fliar Intelligence Index™ 53how this company ranks against its industry peers
AI
top 15%Growth
top 35%Talent
top 38%Funding
top 42%Moat
top 42%Tech
top 43%AI: Holds AI/ML patents (G06N-family CPC)
Growth: Fresh capital in last 24 mo
Talent: 2 named leaders on record · 2 C-suite/founder profiles curated
Audience (LinkedIn): 13k LinkedIn followers — 5.6% of this cohort's audience
Hiring (LinkedIn): 1 hiring post in 12 mo (public) · hiring: Senior Computer Vision Data Scientist
Activity (LinkedIn): 1 awards announced in 12 mo
Funding rounds
- Jan 2026Grant (prize money)—
- Feb 2025Series A$23M
- Dec 2023Seed$8.6M
Founders & team
Investors
LocalGlobe, EmergingTech Ventures, No Label Ventures, Family C Venture, Better Angle, Singular
Tech stack
Animate.CssCloudflareFont AwesomeGoogle Font ApiGoogle Hosted LibrariesGoogle Workspace
#4
Series B · Paris, Ile de France · founded 2015 · 42 employees$2.1Mraised▾
Series B · Paris, Ile de France · founded 2015 · 42 employees
Abbelight provides microscopes, reagents, and software for image analysis. Their 3D fluorescence nanoscopy products include Single Molecule Localization Microscopy (SMLM), high-throughput 2D single-molecule and TIRF imaging, and 3D single-molecule and multi-color imaging. The company also offers smart kits and reagents (dyes) for research use and software that allows the production and manipulation of 3D quantitative data.
Fliar Intelligence Index™ 57how this company ranks against its industry peers
AI
top 15%Product
top 30%Moat
top 32%Innovation
top 40%Patents
top 40%Funding
top 42%AI: Holds AI/ML patents (G06N-family CPC)
Product: 4 distinct product lines · Company stage: Series B
Moat: Editorial + unicorn rating 4/10 · IP moat: 24 patents
Audience (LinkedIn): 5k LinkedIn followers — 2.3% of this cohort's audience
Activity (LinkedIn): 2 awards announced in 12 mo
Funding rounds
- Jan 2026Series B—
- Jul 2023Grant (prize money)$600.7K
- Apr 2022Grant (prize money)$52.7K
- May 2020Grant (prize money)$1.3M
Investors
EIC Fund, Europa, AVANT BIO, Pleiade Venture
Tech stack
Apache Http ServerCloudflareCloudflare Bot ManagementGoogle AnalyticsGoogle Font ApiHttp/3
#5
Seed · Paris, Ile de France · founded 2016 · 29 employees$18Mraised▾
Seed · Paris, Ile de France · founded 2016 · 29 employees
Provider of a device for autologous cell and gene therapies. The company focuses on building high-tech equipment to manufacture autologous cell and gene therapies which include CAR-T or stem cell treatments. The company has developed Lakhesys a microfluidic technology to develop cellular therapies for various disease conditions.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 6k LinkedIn followers — 2.8% of this cohort's audience
Funding rounds
- Dec 2024Grant (prize money)$7.4M
- Oct 2023Grant (prize money)$1.1M
- Jun 2023Seed$18M
- Feb 2022Grant (prize money)$56.3K
Founders & team
Investors
Government of France, EIC Fund, Europa, AdBio partners, M Ventures, Johnson & Johnson Innovation
Tech stack
Apache Http ServerBabelCloudflareCloudflare Bot ManagementComplianzCore-Js
#6
Series A · Paris, Ile de France · founded 2020$5Mraised▾
Series A · Paris, Ile de France · founded 2020
Developer of single-cell therapeutics solutions to treat multiple health disorders. The company's proprietary platform uses single-cell RNA and DNA sequencing that helps to analyze disease-causing agents and provides treatment solutions. The company has developed single-cell computational software for the analysis of genomic data.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 8k LinkedIn followers — 3.4% of this cohort's audience
Activity: 1 partnerships · 2 awards · 1 expansions (incl. Guddine Roussy) announced in 12 mo
Funding rounds
- Jul 2025Series A$17.4M
- Sep 2022Series A$5M
Founders & team
Investors
Galion.exe, Invus, Adamed, Sofinnova Investments, Polytechnique Ventures, Kima Ventures
Tech stack
FlywheelGsapMicrosoft 365MysqlOpen GraphOvhcloud
#7
Series C · Paris, Ile de France · founded 2014 · 202 employees$315Mraised▾
Series C · Paris, Ile de France · founded 2014 · 202 employees
DNA script is a developer of a benchtop DNA printer powered by enzymatic technology for nucleic acid syntheis. It is offering a benchtop DNA printer that provides outsourced chemical-based DNA synthesis through enzymatic synthesis technology to synthesize DNA.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 24k LinkedIn followers — 10.6% of this cohort's audience
Funding rounds
- Sep 2023Grant (prize money)$4.3M
- Jan 2022Series C$35M
- Oct 2021Series C$165M
- Sep 2021Grant (prize money)$280K
Founders & team
Investors
Europa, EIC Fund, DARPA, eureKARE, T. Rowe Price, Baillie Gifford
Tech stack
AosBootstrapBugherdCloudflareCloudflare Bot ManagementFancybox
#8
Seed · Paris, Ile de France · founded 2018 · 17 employees$1.3Mraised▾
Seed · Paris, Ile de France · founded 2018 · 17 employees
EVerZom develops a technology platform for the production of extracellular vesicles. The extracellular vesicles are generated by Mesenchymal stem cells having regenerative properties. This method can be used to apply turbulence stimulation to cells.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 7k LinkedIn followers — 3.1% of this cohort's audience
Activity: 1 partnerships (incl. GENFIT) announced in 12 mo
Funding rounds
- Jun 2025Grant (prize money)$3.5M
- Jun 2022Grant (prize money)$118.7K
- May 2022Grant (prize money)$1.8M
- Nov 2021Grant (prize money)$3.4M
Founders & team
Investors
EIC Fund, Europa, Bpifrance, Erganeo
Tech stack
CloudflareCloudflare Bot ManagementComplianzGoogle Font ApiHstsHttp/3
#9
Series D · Paris, Ile de France · founded 2013 · 75 employees$179.5Mraised▾
Series D · Paris, Ile de France · founded 2013 · 75 employees
Provider of a technology platform for the discovery of antibody-based drugs. The platform combines high throughput, single-cell, functional-based screening of entire B cell (Ab producing cells) populations with next-generation sequencing and rapid DNA synthesis for rare antibody drugs.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 10k LinkedIn followers — 4.4% of this cohort's audience
Funding rounds
- Jun 2021Series D$75M
- Aug 2019Series C$67M
- May 2018Series B$37.5M
- Series A—
Founders & team
Investors
Sequoia Capital, Sherpa Healthcare Partners, Maison Capital, Grand Mount Capital, HKSTP, TIF
Tech stack
Master SliderWordpressMysqlPhpZurb FoundationGravity Forms
#10
Acquired · Villejuif, Ile de France · founded 2013 · 100 employees$53.1Mraised▾
Acquired · Villejuif, Ile de France · founded 2013 · 100 employees
Developer of digital PCR solution for research. The system works on the principle of Crystal Digital PCR in a compact and reliable digital PCR solution with a single consumable. The device is assisted by Crystal Miner software for analyzing the generated data and identifying positive and negative droplets for all 3 fluorescence channels.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 14k LinkedIn followers — 6.1% of this cohort's audience
Funding rounds
- Nov 2021Conventional Debt$22.5M
- Nov 2021Series B$12.7M
- Feb 2020Series B$22.1M
- Nov 2018Series A$18.3M
Founders & team
Investors
Illumina Ventures, Kurma Partners, LBO France, Paris Saclay Seed Fund, BNP Paribas Developpement, Enlighten Holdings
#11
Funding Raised · Paris, Ile de France · founded 2011 · 32 employees$22.7Mraised▾
Funding Raised · Paris, Ile de France · founded 2011 · 32 employees
Metafora biosystems offers diagnostic tests and research reagents (IVD platform for drug discovery, development). They have developed few probes called RBDs which attaches to the transporters to analyze their quantity. Using the technology they have developed METAglut1 blood test to diagnose the GLUT1 deficiency syndrome (GLUT1 DS) which happens because of impairment of the major glucose transporter 1. It has an ability to target nutrient transporters at the cell surface.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 3k LinkedIn followers
Funding rounds
- Jan 2023Grant (prize money)$2.7M
- Oct 2022Grant (prize money)$8.5M
- Jun 2020Grant (prize money)$3.6M
- Jun 2018Grant (prize money)$3.8M
Founders & team
Investors
EIC Fund, Europa, BigBooster
Tech stack
WordpressMysqlPhpGoogle MapsWpbakeryApache Http Server
#12
Seed · Paris, Ile de France · founded 2020 · 15 employees$11.2Mraised▾
Seed · Paris, Ile de France · founded 2020 · 15 employees
Developer of a device for in vitro cancer testing using a microfluidic chip. The company's proprietary technology can be used for personalised treatment and testing of cancer cells in 3D spheroids. It is used for the study of tumour biopsy.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 9k LinkedIn followers — 4.1% of this cohort's audience
Funding rounds
- Dec 2023Seed$11.2M
Founders & team
Investors
Polytechnique Ventures, Berkeley SkyDeck Fund, Resonance, Otium Capital, Berkeley SkyDeck, Village Capital
Funding & investor landscape
$843.6Mtotal disclosed funding
39companies funded
130disclosed rounds
1rounds last 90 days
Most active investors
Bpifrance6 rounds
Notable founders
Regis Nouaille
Co-Founder · AFYREN
Nicolas Sordet
Founder & CEO · AFYREN
Adèle James
Co-Founder & CTO · Phagos
Alexandros Pantalis
Co-Founder & CEO · Phagos
Amine Raji
Co-Founder & CEO · Spore Biotechnologies
Maxime Mistretta
Co-founder & CTO · Spore Biotechnologies
Jeremie Laurent
Founder & CEO · Astraveus
Celine Vallot
Co-Founder · One Biosciences
David Schilansky
Co-Founder · One Biosciences
Xavier Godron
Co-founder & CTO · DNA Script
Max Piffoux
Co-Founder & CTO · EVerZom
Jeanne Volatron
Co-Founder & CEO · EVerZom
Prism market signals · France · country-scoped Prism corpus, 2,902,929 docs
Market landscape — 10 sub-themes by coverage
Share of Life Sciences Platforms and Tools coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
RESEARCH SIGNALS · France
How research on Bioinformatics is moving in France
A read on the academic research around Bioinformatics — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 1,937 France-affiliated papers.
research sentiment over time
200820162030
enthusiastic · positive · guarded tone
Tone is overwhelmingly optimistic and softening — the enthusiastic (strongly-positive) share moved 48% → 44% across 2008–2030.
top research entities
- Centre National de la Recherche Scientifique581
- Inserm393
- Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement130
- Assistance Publique – Hôpitaux de Paris112
- European Molecular Biology Laboratory87
leading researchers
Engelhorn, Julia · Valentin Sorin · Damian Szklarczyk · Andrew Mc Carthy · Maulana M. Naji · Lars Juhl Jensen · Peer Bork · F. Besnard
▲
Breakthroughs770 · 40%
40%→40% share
▲1.0× share momentum0 median citations87% since 2021mostly methods-led
Breakthroughs are cooling (40%→40% of field), led by Genome.
rising sub-themes (early→recent)
- Genome15→94
- Gene20→91
- Transcriptome2→53
- Chromatin2→28
- Identification (biology)2→27
Newly emergingDisease 0→30 · Workflow 0→24 · In silico 0→20
Landmark Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 · 97,164 cites
◆
Advancements532 · 27%
▲ 19%→28% share
▲1.5× share momentum0 median citations89% since 2021mostly empirical
Advancements are rising (19%→28% of field), led by Gene.
rising sub-themes (early→recent)
- Gene4→56
- Transcriptome3→39
- Genome5→24
- Biomarker1→17
- In silico1→16
Newly emergingDisease 0→39 · Immune system 0→23 · Cancer 0→19
Landmark Differential expression analysis for sequence count data · 16,273 cites
▼
Concerns285 · 15%
▼ 21%→14% share
▼0.7× share momentum0 median citations83% since 2021mostly reviews
Concerns are cooling (21%→14% of field), led by Disease.
rising sub-themes (early→recent)
- Disease3→34
- Gene1→19
- Cancer2→17
- Clinical trial2→16
- Immune system2→14
Newly emergingTranscriptome 0→12 · Adverse effect 0→10 · MEDLINE 0→9
Landmark A standardised staticin vitrodigestion method suitable for food – an international consensus · 5,317 cites
RESEARCH HOTSPOTS · France
Where bioinformatics is researched across France
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Paris554 · +0.49
Marseille75 · +0.51
Lyon69 · +0.49
Grenoble50 · +0.48
Toulouse45 · +0.41
Strasbourg38 · +0.51
PATENT SIGNAL · France
Who's filing bioinformatics patents in France
France bioinformatics patent filing is steady — 2 filings from 4 assignees (2024–2025), led by UNIV Paris CITE, Centre NAT RECH Scient, Ecole NAT Superieure DE Chimie P; annual filings 1→1.
2 filings4 assigneespeak 1/yr2024–2025
filing momentum (YoY 2024–2025)
top patent filers
- UNIV Paris CITE2
- Centre NAT RECH Scient2
- Ecole NAT Superieure DE Chimie P1
- Ecole NAT Superieure DE Chimie D1
Common questions
How many Life Sciences Platforms and Tools companies are there in Ile de France, France?
Radar tracks 74 indexable Life Sciences Platforms and Tools companies headquartered in Ile de France, France that meet our profile-completeness bar.
What is the total funding raised by Life Sciences Platforms and Tools companies in Ile de France, France?
The Life Sciences Platforms and Tools companies in Ile de France, France on this list have raised a combined $843.6M in disclosed equity funding across 39 funded companies.
Which is the highest-funded Life Sciences Platforms and Tools company in Ile de France, France?
DNA Script is the highest-funded Life Sciences Platforms and Tools company in Ile de France, France, with $315M in disclosed equity funding.
How many Life Sciences Platforms and Tools companies in Ile de France, France are funded?
39 of the 74 Life Sciences Platforms and Tools companies in Ile de France, France on this list have disclosed at least one equity funding round.
How many Life Sciences Platforms and Tools unicorns are there in Ile de France, France?
None of the Life Sciences Platforms and Tools companies in Ile de France, France on this list currently has a disclosed valuation of $1B or more.
Who are the top investors in Ile de France, France Life Sciences Platforms and Tools companies?
The most active investors in Ile de France, France Life Sciences Platforms and Tools companies on this list include Europa, EIC Fund, Bpifrance, Entrepreneur First, Casdin Capital.
Rohit KhannaTrends & Stories
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.